All In MedTech

Device Trial Radar · NCT07444749

Trillium Validation Study

A Phase III Randomized Crossover Study to Validate the Clinical Safety, Performance, and Benefit of the Trillium Full Face Mask in Patients With Obstructive Sleep Apnea

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

45

Actual

Start

Apr 21, 2026

Primary completion

May 28, 2026

Study completion May 28, 2026

Sponsor

Sponsor type
Industry
Collaborators
Florida Lung & Sleep Associates
First posted
Mar 3, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 21 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This will be a single-center, two-treatment, two-period, open-label, randomized crossover design pivotal study to validate the clinical safety, clinical performance, and clinical benefits of the Trillium Full Face Mask (FFM).

Conditions

  • Sleep Apnea, Obstructive

Interventions

  • TrilliumDevice

    The Trillium Full Face Mask (FFM) (Philips Respironics, Murrysville, PA) is an over-the-nose, full-face mask with the hose connection in the front. The Trillium Full Face Mask is intended to provide an interface for the application of non-invasive positive airway pressure (PAP) therapy. The mask is intended for single-patient reuse in the home environment and healthcare facilities and/or hospital environments. The mask is to be used by adult patients weighing more than 66lb (30kg) for whom non-invasive PAP therapy has been prescribed. The device is not intended for critical care patients.

  • AirFit F20Device

    The AirFit F20 (ResMed, San Diego, California) is an externally placed vented mask covering the mouth and the nose of the patient. It provides a seal such that pressure from a positive pressure source is directed to the patient's nose and/or mouth. The mask connects via a standard conical connector to a conventional air delivery hose, which in turn connects to the positive pressure source. The mask is held in place with an adjustable headgear that straps the mask to the face. The AirFit F20 mask system comprises four subassemblies: cushion, frame, elbow and headgear. The elbow incorporates the vent array and anti-asphyxia valve safety features. The cushion and headgear are available in various sizes to fit a wide patient population. AirFit F20 is a prescription device supplied non-sterile.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Median Unintentional LeakTime frame: During each approximately 15-day treatment period

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Florida Lung and Sleep Associates

    Fort Myers, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.